A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension

scientific article published on 14 March 2019

A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/IJERPH16060923
P932PMC publication ID6466102
P698PubMed publication ID30875817

P50authorShahid MahboobQ87611652
Rana Muhammad AtifQ91075145
Syed Awais AttiqueQ92392976
Muhammad BilalQ86180171
P2093author name stringMuhammad Usman
Muhammad Hassan
Khalid A Al-Ghanim
Muhammad Zohaib Nawaz
P2860cites workAttenuation of oxidative stress, inflammation, and endothelial dysfunction in hypercholesterolemic rabbits by allicinQ86829893
Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazaprilQ87146445
Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discoveryQ45787855
Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study).Q46078750
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsQ46217490
Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND PatientsQ49642892
DOCKTITE-a highly versatile step-by-step workflow for covalent docking and virtual screening in the molecular operating environment.Q50989579
2D depiction of protein-ligand complexes.Q51907376
Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0.Q51922137
A Validated HPLC Method for Simultaneous Determination of Perindopril Arginine, Amlodipine, and Indapamide: Application in Bulk and in Different Pharmaceutical Dosage Forms.Q53739069
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.Q54061484
Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysisQ56893651
Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension studyQ56970838
Fosinopril monotherapy: relationship between blood pressure reduction and time of administrationQ70623145
GlamDock: development and validation of a new docking tool on several thousand protein-ligand complexesQ80514687
The RCSB PDB information portal for structural genomicsQ24538661
Angiotensin-I-converting enzyme and its relativesQ24796698
Hypertension and Related Cardiovascular Disease Burden in ChinaQ26745496
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingQ27860652
The PSIPRED protein structure prediction serverQ27860953
PubChem Substance and Compound databasesQ27942588
Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engineQ28207735
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracyQ28251042
A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small MoleculesQ28822513
MEME SUITE: tools for motif discovery and searchingQ29547204
Spectroscopic Determination of Tryptophan and Tyrosine in Proteins*Q29555850
Improved protein-ligand docking using GOLDQ29616787
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsQ29619542
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.Q30353189
Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisionsQ30387813
Comparative evaluation of eight docking tools for docking and virtual screening accuracyQ33206310
Haematopoietic effects of Angelica sinensis root cap polysaccharides against lisinopril-induced anaemia in albino rats.Q33364402
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysisQ33826989
A geometric approach to macromolecule-ligand interactionsQ34280176
The many roles of computation in drug discoveryQ34307063
Using the Global Burden of Disease study to assist development of nation-specific fact sheets to promote prevention and control of hypertension and reduction in dietary salt: a resource from the World Hypertension LeagueQ34460970
Integration of virtual and high-throughput screeningQ34988235
Genetics of human hypertensionQ35613051
The MEME SuiteQ35810173
Structural identification of degradants of moexipril by LC-MS/MS.Q36368760
Structure-based drug design to augment hit discoveryQ37910375
Lead- and drug-like compounds: the rule-of-five revolutionQ38225014
Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study.Q38387633
Angiotensins as therapeutic targets beyond heart disease.Q38408467
Fosinopril Prevents the Development of Tactile Allodynia in a Streptozotocin-Induced Diabetic Rat ModelQ40562632
Natural products in drug discovery and developmentQ41334729
Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive ratsQ41945916
The angiotensin converting enzyme (ACE) inhibitor, captopril disrupts the motility activation of sperm from the silkworm, Bombyx moriQ41985803
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesQ42318665
LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sitesQ44247315
FlexX-Scan: fast, structure-based virtual screeningQ45070169
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectMolecular DockingQ57976073
P304page(s)923
P577publication date2019-03-14
P1433published inInternational Journal of Environmental Research and Public HealthQ6051382
P1476titleA Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension
P478volume16

Search more.